Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.56 |
| ▸ | CDC25B | P30305 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | MAOA | P21397 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | CDC25A | P30304 | 2/20 | 0.56 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.56 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.56 |
| ▸ | MAOB | P27338 | 2/20 | 0.56 |
| ▸ | SNCA | P37840 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29633271 | 1.00 | IDO1 (0.56) | IDO1CDC25BMAPTMAPK1MEN1 | |
| SCHEMBL11566065 | 0.85 | IDO1 (0.50) | IDO1CDC25BMAPTMAPK1MEN1 | |
| SCHEMBL2529860 | 0.81 | PTPRC (0.59) | IDO1CDC25BMAPTMAPK1MEN1 | |
| SCHEMBL13464147 | 0.79 | IDO1 (0.52) | IDO1CDC25BMAPTMAPK1MEN1 | |
| SCHEMBL8661355 | 0.79 | GAPDH (0.49) | IDO1CDC25BMAPTMAPK1MEN1 | |
| SCHEMBL7997569 | 0.77 | SLC2A1 (0.57) | IDO1CDC25BMAPTMAPK1MEN1 | |
| SCHEMBL9628450 | 0.77 | MEN1 (0.58) | CDC25BMAPTMEN1KMT2ALMNA | |
| SCHEMBL5091710 | 0.76 | CDC25B (0.48) | IDO1CDC25BMAPTMAPK1MEN1 | |
| SCHEMBL8773066 | 0.76 | S100A4 (0.56) | AURKAAURKBS100A4PTPRCCES2 | |
| SCHEMBL9629435 | 0.76 | S100A4 (0.61) | AURKAAURKBS100A4CES1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 500 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118307552-A | H can be detected based on Rhodol structures2S fluorescent probe preparation method and application | 四川轻化工大学 | 2024-07-09 | — | — | CN | claimed |
| CN-118291005-A | Preparation method of photosensitive drum coating material | 新印科技股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| US-20230150895-A1 | SOIL CONDITIONER AND USE THEREOF | JAPAN INTERNATIONAL RESEARCH CENTER FOR AGRICULTURAL SCIENCES (JP) | 2023-05-18 | — | — | US | claimed |
| EP-4180502-A1 | SOIL CONDITIONER AND USE THEREOF | Japan International Research Center for Agricultural Sciences (JP) | 2023-05-17 | — | — | EP | claimed |
| CN-112479950-B | Preparation process of PIN1 inhibitor | 烟台共进医药科技有限公司 | 2023-03-10 | — | — | CN | claimed |
| CN-115305245-A | Preparation method of small molecule compound and novel coronavirus main protease protein cocrystal | 山东达因海洋生物制药股份有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-114563494-A | Method for detecting halogenated naphthoquinone in drinking water by solid phase extraction, vacuum centrifugal concentration and liquid chromatography tandem mass spectrometry | 浙江大学 | 2022-05-31 | — | — | CN | claimed |
| CN-112479950-A | Preparation process of novel PIN1 inhibitor | 烟台共进医药科技有限公司 | 2021-03-12 | — | — | CN | claimed |
| CN-111423428-A | Organic compound, preparation method thereof and organic light-emitting diode | 广东聚华印刷显示技术有限公司 | 2020-07-17 | — | — | CN | claimed |
| CN-111372609-A | Sonodynamic therapy | 阿尔斯特大学 | 2020-07-03 | — | — | CN | claimed |
| EP-1051909-A1 | The treatment of pests using substituted naphthoquinones | Sorex Limited (GB) | 2000-11-15 | — | — | EP | claimed |
| CN-1249687-A | Compositions and methods for reducing ocular hypertension | NOVARTIS AG (CH) | 2000-04-05 | — | — | CN | claimed |
| EP-0436921-B1 | Inhibitor concentrate, storage stable unsaturated thermosettable resins and cured products | DOW CHEMICAL CO (US) | 1997-03-12 | — | — | EP | claimed |
| EP-0244309-B1 | RODENTICIDAL COMPOSITIONS CONTAINING 1,4-NAPHTHOQUINONE DERIVATIVES | DUKE UNIVERSITY (US) | 1993-02-03 | — | — | EP | claimed |
| CN-1053248-A | Inhibitor concentrate and can stablize the unsaturated thermosetting resin and the solidified product of storage | DOW CHEMICAL CO (US) | 1991-07-24 | — | — | CN | claimed |
| CN-1043177-A | Carry out the method for dyeing keratinous fibres and new 1,4-benzoquinones with oxyindole and quinone derivative | OREAL (FR) | 1990-06-20 | — | — | CN | claimed |
| US-4734282-A | Rodenticidal compositions containing 1,4-naphthoquinone derivatives | DUKE UNIVERSITY (US) | 1988-03-29 | — | — | US | claimed |
| EP-0244309-A2 | Rodenticidal compositions containing 1,4-naphthoquinone derivatives | DUKE UNIVERSITY (US) | 1987-11-04 | — | — | EP | claimed |
| US-4460674-A | GALLIC ACID DERIVATIVES AND NAPOHTHOQUINONES | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-07-17 | — | — | US | claimed |
| US-4220528-A | CONTACTING A GAS WITH A SOLUTION CONTAINING A HYDRAZINE, A QUINONE, AN ALKALI; CONTACTING THE DEOXYGENATED GAS WITH WATER | OTSUKA CHEMICAL CO., LTD. (JP) | 1980-09-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150895-A1 | SOIL CONDITIONER AND USE THEREOF | H1-0, ARG1, H1-2 | IDO1 92/4885CDC25B 2996/4885MAPT 4216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.